Christopher Volker
Geschäftsführer bei NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Vermögen: 83 250 $ am 30.04.2024
Profil
Christopher R.
Volker is currently the Chief Operating Officer at NeuroOne Medical Technologies Corp.
Prior to this, he was the Vice President & General Manager-International at Cardiovascular Systems, Inc. from 2017 to 2023.
He also worked at Abbott Laboratories as the Head-Commercial Integration.
Mr. Volker completed his undergraduate degree at Saint John's University and earned an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.12.2023 | 75 000 ( 0,29% ) | 83 250 $ | 30.04.2024 |
Aktive Positionen von Christopher Volker
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Geschäftsführer | 10.11.2023 |
Ehemalige bekannte Positionen von Christopher Volker
| Unternehmen | Position | Ende |
|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | Corporate Officer/Principal | 01.08.2023 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.04.2023 |
Ausbildung von Christopher Volker
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Saint John's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
